VKTX — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Viking Therapeutics, Inc.
Healthcare · $28.38
1.0
/10
Poor Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-14.3%
Below trend
Volatility
High
Rich premiums
Momentum
Decelerating
6th day
About Viking Therapeutics, Inc.
Viking Therapeutics is a clinical-stage biotech developing VK2735, a GLP-1/GIP dual agonist for obesity, in Phase 3 trials. High beta, no dividend, sentiment-driven swings tied to trial data and obesity-drug competition. Rich premiums but extreme gap risk around data readouts makes CSP selling high-risk.
Biotechnology
Market Cap
$3.6B
P/E Ratio
—
Beta
0.65
Forward P/E
-6.5
52-Week Range Current: $28.38
$25.77 $43.15
Earnings
2026-10-28
21 days away

VKTX — earnings on 2026-10-28 (21 days) split the expiry calendar. Contracts ending before the report and contracts crossing it carry materially different exposure profiles, even at identical strikes.

Based on end-of-day market dataScored by ThetaLoop Research
VKTX ranks #37 of 66 Healthcare tickers by put-selling score (617 total screened)

Position Size & Yield Calculator

Live model for VKTX — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
ELV Elevance Health, Inc. 8.7 JNJ Johnson & Johnson 8.7 REGN Regeneron Pharmaceuticals, Inc. 8.0 CNC Centene Corporation 7.9 MRK Merck & Co., Inc. 7.2 Browse all Healthcare tickers →
📌 Embed this score on your blog
The VKTX X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/VKTX" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/VKTX">VKTX X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →